NM_004453.4:c.807A>C

Subject ID	Country of Origin	Allele Count	CTGA Clinical Significance	Condition(s)	Reference	Remarks
231680.1	United Arab Emirates	2	Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Ali et al. 2021
231680.2.1	United Arab Emirates	2	Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Ali et al. 2021
231680.2.2	United Arab Emirates	2	Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Ali et al. 2021	Sibling of 231680.2.1
231680.2.3	United Arab Emirates	2	Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Ali et al. 2021	Sibling of 231680.2.1. Mild presentation
231680.2.4	United Arab Emirates	2	Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Ali et al. 2021	Sibling of 231680.2.1. Mild presentation
231680.3	United Arab Emirates	2	Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Ali et al. 2021	Mild presentation
231680.4	United Arab Emirates	2	Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Ali et al. 2021	Mild presentation
231680.5	United Arab Emirates	2	Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Ali et al. 2021	Asymptomatic
231680.6	United Arab Emirates	2	Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Ali et al. 2021
231680.G.1	United Arab Emirates	8	Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Al-Shamsi et al. 2014	Group of 4 unrelated patients
231680.G.2	United Arab Emirates		Likely Pathogenic	Multiple Acyl-CoA Dehydrogenation Deficiency	Al-Jasmi at al. 2016	Mutations identified in two Emiratis

Epidemiology in the Arab World